Leading ITP Haematologists from THANZ come together and deliver consensus guidelines for the treatment of immune thrombocytopenia in adult patients across Australia and New Zealand.
ATAGI recommendations on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised.
A joint statement from the Australian Technical Advisory Group on Immunisation (ATAGI) and the Thrombosis and Haemostasis society of Australia and New Zealand (THANZ) on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZeneca.
ATAGI has released a number of recommendations relating to the COVID-19 Vaccine.
Dr Norman Swan hosts an ABC podcast called ‘Coronacast’, where they talk all things COVID-19. In a recent episode, he talks about the vaccines, the occurrence of blood clots and ITP.
Australian experts confident in AstraZeneca vaccine despite pause in Europe
7.30 with Leigh Sales (ABC), Dr Norman Swan discussed the the most scrutinised vaccine rollout in history, with the COVID-19 vaccine.
A statement from the ITP Australia Medical Advisory Board regarding the COVID-19 Vaccine.
Learn more about our international medical advisor and Paediatric ITP specialist, Michele Lambert as she shares a little about why she’s so passionate about paediatric ITP.
We wanted to get to know each of our ITP Australia Medical Advisory Board members a little more so we caught up with Terry recently to find out a little more about her and why she does the amazing things that she does.
At around this time each year in Australia, many ITP patients ask their primary care professional, whether it’s their GP or haematologist if they should be getting the annual influenza vaccine and there are always varying responses.
Dr Robert Bird, member of our Medical Advisory Board, has shared information about ITP patients being at an increased risk of blood clots and not just bleeding.
Welcome to the second edition of The Count.
In this edition, we have an update on the recently updated and published International Consensus Report for the diagnosis and management of ITP, an update of emerging treatments showcased at the 2019 American Society of Hematology Conference in Orlando Florida, details on the Local Patient Meetings, plus some information around blood clots and ITP Patients.